Arvinas (ARVN) EBT Margin (2017 - 2026)

Arvinas' (ARVN) quarterly EBT Margin came in at 368.59% in Q1 2026, down 41260.0% year-on-year from N/an in Q1 2025, and up 47.89% quarter-over-quarter from 707.37% in Q4 2025.

Arvinas (ARVN) EBT Margin (2017 - 2026) Analysis & Trends

Arvinas' EBT Margin history runs 10 years deep, the most recent figure standing at 368.59% for Q1 2026.

  • On a quarterly basis, EBT Margin fell 41260.0% year-over-year to 368.59% in Q1 2026; TTM through Mar 2026 was 247.2%, a 23643.0% decrease from a year earlier, with the FY2025 full-year figure at 30.65%, up 4463.0% from the prior year.
  • EBT Margin climbed to 368.59% in Q1 2026 per ARVN's latest filing, from 707.37% in the prior quarter.
  • Across five years, EBT Margin topped out at 355.45% in Q4 2023 and bottomed at 707.37% in Q4 2025.
  • The 5-year median for EBT Margin is 184.04% (2022), against an average of 164.92%.
  • Across the five-year window, EBT Margin surged 72490 bps in 2022 and sank 63051 bps in 2025, its largest moves.
  • Year by year, EBT Margin stood at 183.33% in 2022, then surged by 294 bps to 355.45% in 2023, then plunged by 122 bps to 76.86% in 2024, then plunged by 820 bps to 707.37% in 2025, then soared by 48 bps to 368.59% in 2026.
  • Per Business Quant, the three latest ARVN EBT Margin figures stand at 368.59% (Q1 2026), 707.37% (Q4 2025), and 83.05% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Arvinas 519.68 Mn -95.22 Mn - -368.59%

Historic Data

Download Data
DateValue
Mar 31, 2026 -368.59%
Dec 31, 2025 -707.37%
Sep 30, 2025 -83.05%
Jun 30, 2025 -274.55%
Mar 31, 2025 44.01%
Dec 31, 2024 -76.86%
Sep 30, 2024 -47.46%
Jun 30, 2024 -45.75%
Mar 31, 2024 -273.91%
Dec 31, 2023 355.45%
Sep 30, 2023 -184.68%
Jun 30, 2023 -120.37%
Mar 31, 2023 -249.85%
Dec 31, 2022 -183.33%
Sep 30, 2022 -184.04%
Jun 30, 2022 -189.64%
Mar 31, 2022 -213.58%
Dec 31, 2021 -138.86%
Sep 30, 2021 -503.23%
Jun 30, 2021 -914.55%